Abstract:Background Peripheral T-cell lymphomas (PTCLs) are often aggressive tumors and resistant to conventional chemotherapy. Dysregulation of extrinsic apoptosis plays an important role on tumor cell sensitivity to chemotherapeutic agents. Cellular FLICE inhibitory protein (c-FLIP) is a key regulator of extrinsic apoptotic pathway. Methods c-FLIP expression was assessed by real-time PCR and compared according to clinical parameters in patients with PTCLs. The relation of c-FLIP to tumor cell apoptosis mediated by histone deacetylases inhibitors (HDACIs) and the possible mechanism were examined in T-lymphoma cell lines and in a murine xenograft model. Results c-FLIP was overexpressed and associated with decreased tumor TRAIL/DR5 expression, elevated serum lactate dehydrogenase level and high-risk International Prognostic Index of the patients. In vitro, molecular silencing of c-FLIP by specific small-interfering RNA increased TRAIL/DR5 expression, enhanced T-lymphoma cell apoptosis and sensitized cells to chemotherapeutic agents. However, HDACIs valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA) could downregulate c-FLIP expression and triggered extrinsic apoptosis of T-lymphoma cells, through inhibiting NF-κB signaling and interrupting P50 interaction with c-FLIP promoter. As Class I HDACIs, both VPA and SAHA inhibited HDAC1, resulting in P50 inactivation and c-FLIP downregulation. In vivo, oral VPA treatment significantly retarded tumor growth and induced in situ apoptosis, consistent with inhibition of HDAC1/P50/c-FLIP axis and increase of TRAIL/DR5 expression. Conclusions c-FLIP overexpression in PTCLs protected tumor cells from extrinsic apoptosis and contributed to tumor progression. Although linking to chemoresistance, c-FLIP indicated tumor cell sensitivity to HDACIs, providing a potential biomarker of targeting apoptosis in treating PTCLs.

An Essential Role for C-Flip in the Efficient Development of Mature T Lymphocytes.

C-Flip Protects Mature T Lymphocytes from Tcr-Mediated Killing

FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIP

FLIP: a Novel Regulator of Macrophage Differentiation and Granulocyte Homeostasis

TNF Is Partially Required for Cell-Death-Triggered Skin Inflammation upon Acute Loss of cFLIP

Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair

Nuclear Localization of C-Flip-l and Its Regulation of AP-1 Activity

Specific Ablation of the Apoptotic Functions of Cytochrome C Reveals a Differential Requirement for Cytochrome C and Apaf-1 in Apoptosis

Protective Roles for Caspase-8 and cFLIP in Adult Homeostasis

Developing and Activated T Cell Survival Depends on Differential Signaling Pathways to Regulate Anti-Apoptotic Bcl-x(L).

Caspase-8 auto-cleavage regulates programmed cell death and collaborates with RIPK3/MLKL to prevent lymphopenia

c-FLIP and CD95 signaling are essential for survival of renal cell carcinoma

Protein Phosphatase 2A Has an Essential Role in Promoting Thymocyte Survival During Selection

c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors

MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment

Requirement for Casper (c-FLIP) in Regulation of Death Receptor–Induced Apoptosis and Embryonic Development

Cellular FLICE-inhibitory protein protects against cardiac remodeling induced by angiotensin II in mice.

Bclaf1 Regulates C-Flip Expression and Protects Cells from TNF-induced Apoptosis and Tissue Injury.

Apoptosis in the development of the immune system

The Short Splice Form of Casper/C-Flip is A Major Cellular Inhibitor of Trail-Induced Apoptosis

Apoptosis Signaling Pathways and Lymphocyte Homeostasis